NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · IEX Real-Time Price · USD

21.99

+0.55 (2.57%)

At close: Apr 26, 2024, 4:00 PM

21.85

-0.14 (-0.64%)

After-hours: Apr 26, 2024, 6:25 PM EDT

NAMS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	1,963	1,087	847	173	134
Market Cap Growth	-	28.43%	389.21%	29.00%	-
Enterprise Value	1,599	709	349	113	132
PE Ratio	-5.53	-5.53	-35.16	-3.64	-19.14
PS Ratio	125.39	69.46	7.75	-	-
PB Ratio	6.36	3.39	1.85	3.06	-10.44
P/FCF Ratio	-6.93	-6.93	76.21	-5.16	-18.39
P/OCF Ratio	-6.93	-6.93	74.63	-5.16	-18.43
EV/Sales Ratio	102.13	45.30	3.20	-	-
EV/EBITDA Ratio	-3.61	-3.61	-14.70	-2.40	-20.10
EV/EBIT Ratio	-3.61	-3.61	-14.69	-2.40	-20.10
EV/FCF Ratio	-4.52	-4.52	31.43	-3.36	-18.16
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-
Debt / EBITDA Ratio	0.00	0.00	-0.01	0.00	-
Debt / FCF Ratio	0.00	0.00	0.01	-0.01	-
Quick Ratio	6.95	6.95	13.26	5.96	5.77
Current Ratio	6.95	6.95	13.26	5.96	7.90
Asset Turnover	0.03	0.03	0.38	0	-
Interest Coverage	-	-	-77.86	-100.67	-15.71
Return on Equity (ROE)	-49.30%	-49.30%	-9.40%	-318.40%	-
Return on Assets (ROA)	-42.90%	-42.90%	-8.40%	-35.00%	-
Return on Capital (ROIC)	-63.43%	-63.43%	-0.83%	-70.02%	51.52%
Earnings Yield	-10.02%	-18.08%	-2.84%	-27.44%	-5.23%
FCF Yield	-7.70%	-14.43%	1.31%	-19.39%	-5.44%
Buyback Yield / Dilution	-448.41%	-25.32%	-337.60%	-155.70%	-
Total Shareholder Return	-448.41%	-25.32%	-337.60%	-155.70%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).